Company
Headquarters: New York, NY, United States
Employees: 1
CEO: Dr. Chong Yi Yang
$825,000
USD as of Jan. 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Philip Morris | $148.50 B |
| Altria Group, Inc. | $73.43 B |
| British American Tobacco plc | $67.19 B |
| Japan Tobacco, Inc. | $47.28 B |
| Imperial Brands plc | $20.82 B |
| Company | Market Cap (USD) |
|---|---|
| Walmart | $428.87 B |
| Procter & Gamble | $350.35 B |
| Kweichow Moutai | $299.54 B |
| Costco | $287.69 B |
| L'Oréal | $262.20 B |
Nhale, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of technologies related to the medical marijuana market. The company was formerly known as Gankit Corporation and changed its name to Nhale, Inc. in May 2014. The company was incorporated in 2012 and is based in New York, New York. Nhale, Inc. is a subsidiary of Riverview Heights, LLC.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Nhale, Inc. has the following listings and related stock indices.
Stock: OTC: NHLE wb_incandescent
Headquarters:
42 Mott Street
4th Floor
New York, NY 10013
United States